Allaying fears about meningitis and stroke from potentially contaminated steroid injections, Centegra Health System announced this morning it doesn't use methylprednisolone acetate from the manufacturer fingered by the Centers for Disease Control.
Last week the New England Compounding Center voluntarily recalled three lots of the steroid. The manufacturer Centegra utilizes performs its own quality controls and does not outsource its manufacturing of products to the New England Compounding Center, according to
Centegra’s Director of Pharmacy, Scott Padjen.
Subscribe to:
Post Comments (Atom)


No comments:
Post a Comment